117 However, the subsequent 3-month study of Rennard et al found only a nonsignificant trend toward better quality of life in the salmeterol arm compared to placebo. 118 The early studies found no difference in mortality between LABA and placebo, arguably because of their short durations.
← all excerpts
Exacerbation rate, health status and mortality in COPD--a review of potential interventions.
2
—
—
The sentences
The study showed a highly significant improvement in the salmeterol arm of the study. 75 This was supported by another study which used the CRQ to measure quality of life 116 and a later study using formoterol. 117 However, the subsequent 3-month study of Rennard et al found only a nonsignificant trend toward better quality of life in the salmeterol arm compared to placebo. 118 The early studies found no difference in mortality between LABA and placebo, arguably because of their short durations.